Use of 5HT1B receptor antagonist for the treatment of vascular disease

摘要

PCT No. PCT/EP96/03989 Sec. 371 Date Jul. 1, 1998 Sec. 102(e) Date Jul. 1, 1998 PCT Filed Sep. 9, 1996 PCT Pub. No. WO97/10824 PCT Pub. Date Mar. 27, 1997The present application is directed to the use of 5HT1B or 5HT1D receptor antagonists in the treatment of vascular diseases, in particular angina, Raynaud's syndrome, peripheral vascular syndrome or portal hypertension.